Pancreatic Cancer Research

ResearcherUniversity of Colorado AnschutzNo recent work listed

Miles Piper

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-8458-2524; OpenAlex author ID A5034675773. Sources: OpenAlex.

Their work

Papers
6 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
22
Papers, trials and grants by year

2021: 2 papers · 2022: 1 paper · 2023: 3 papers

Papers 6

  1. Simultaneous targeting of PD-1 and IL-2Rβγ with radiation therapy inhibits pancreatic cancer growth and metastasis. Co-author DOI 10.1016/j.ccell.2023.04.001↗
  2. Vasculitis, CA19-9, and Perineural Invasion Differentially Predict Response and Surgical Outcome in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1016/j.ijrobp.2022.12.039↗
  3. Pancreatic Ductal Adenocarcinoma Cells Regulate NLRP3 Activation to Generate a Tolerogenic Microenvironment. Co-author DOI 10.1158/2767-9764.crc-23-0065↗
  4. Targeting Treg-Expressed STAT3 Enhances NK-Mediated Surveillance of Metastasis and Improves Therapeutic Response in Pancreatic Adenocarcinoma. Co-author DOI 10.1158/1078-0432.ccr-21-2767↗
  5. Response to radiotherapy in pancreatic ductal adenocarcinoma is enhanced by inhibition of myeloid-derived suppressor cells using STAT3 anti-sense oligonucleoti… Co-author DOI 10.1007/s00262-020-02701-w↗
  6. Induction of ADAM10 by Radiation Therapy Drives Fibrosis, Resistance, and Epithelial-to-Mesenchyal Transition in Pancreatic Cancer. First author DOI 10.1158/0008-5472.can-20-3892↗

Closest collaborators

The 22 strongest of 22 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Sana D. Karam · 6 shared papers, 2021–2023 · strength 0.77
  2. Marco Del Chiaro · 4 shared papers, 2021–2023 · strength 0.49
  3. Wells A. Messersmith · 4 shared papers, 2021–2023 · strength 0.45
  4. Karyn A. Goodman · 3 shared papers, 2021–2022 · strength 0.30
  5. Adam Christopher Mueller · 3 shared papers, 2021–2022 · strength 0.30
  6. Richard David Schulick · 3 shared papers, 2021–2022 · strength 0.30
  7. Shuichi Watanabe · 2 shared papers, 2022–2023 · strength 0.30
  8. Michael James Gough · 2 shared papers, 2021 · strength 0.19
  9. Ayman J. Oweida · 2 shared papers, 2021 · strength 0.19
  10. Kirk Charles Hansen · 2 shared papers, 2021 · strength 0.19
  11. Carlo Marchetti · 1 shared paper, 2023 · strength 0.15
  12. Alexis Diane Leal · 1 shared paper, 2023 · strength 0.15
  13. Jesús Amo‐Aparicio · 1 shared paper, 2023 · strength 0.15
  14. Christopher Hanyoung Lieu · 1 shared paper, 2023 · strength 0.15
  15. Robert William Lentz · 1 shared paper, 2023 · strength 0.15
  16. Todd M. Pitts · 1 shared paper, 2023 · strength 0.15
  17. Christian Klein · 1 shared paper, 2023 · strength 0.13
  18. Angelo D’Alessandro · 1 shared paper, 2023 · strength 0.13
  19. Yuwen Zhu · 1 shared paper, 2022 · strength 0.11
  20. Martin D. McCarter · 1 shared paper, 2021 · strength 0.09
  21. Sara Zakem · 1 shared paper, 2021 · strength 0.09
  22. David Lagares · 1 shared paper, 2021 · strength 0.09

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.